Relative mortality and survival in multiple sclerosis: Findings from British Columbia, Canada

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 1, 2012, Pages 61-66

  Kingwell, E ^a   Van Der Kop, M ^a   Zhao, Y ^a   Shirani, A ^a   Zhu, F ^a   Oger, J ^a   Tremlett, H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; IMMUNOMODULATION; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MIGRATION; MORTALITY; MULTIPLE SCLEROSIS; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TIME;

EID: 84155167646     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-300616     Document Type: Article

References (38)

1. Riise T, Gronning M, Aarli JA, et al. Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models. J Clin Epidemiol 1988;41:1031-6. (Pubitemid 19002072)
2. Poser S, Kurtzke JF, Poser W, et al. Survival in multiple sclerosis. J Clin Epidemiol 1989;42:159-68. (Pubitemid 19069806)
3. Bronnum-Hansen H, Koch-Henriksen N, Hyllested K. Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey. Neurology 1994;44:1901-7. (Pubitemid 24319218)
4. Bronnum-Hansen H, Koch-Henriksen N, Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 2004;127:844-50. (Pubitemid 38478529)
5. Wallin MT, Page WF, Kurtzke JF. Epidemiology of multiple sclerosis in US veterans. VIII. Long-term survival after onset of multiple sclerosis. Brain 2000;123:1677-87. (Pubitemid 30481191)
6. Sumelahti ML, Tienari PJ, Wikstrom J, et al. Survival of multiple sclerosis in Finland between 1964 and 1993. Mult Scler 2002;8:350-5. (Pubitemid 34784764)
7. Grytten Torkildsen N, Lie S, Aarseth J, et al. Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway. Mult Scler 2008;14:1191-8.
8. Hirst C, Swingler R, Compston DA, et al. Survival and cause of death in multiple sclerosis: a prospective population-based study. J Neurol Neurosurg Psychiatry 2008;79:1016-21.
9. Smestad C, Sandvik L, Celius EG. Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients. Mult Scler 2009;15:1263-70.
10. Hader WJ. Disability and survival of multiple sclerosis in Saskatoon, Saskatchewan. Can J Neurol Sci 2010;37:28-35.
11. Leray E, Morrissey SP, Yaouanq J, et al. Long-term survival of patients with multiple sclerosis in West France. Mult Scler 2007;13:865-74. (Pubitemid 351540857)
12. Sadovnick AD, Ebers GC, Wilson RW, et al. Life expectancy in patients attending multiple sclerosis clinics. Neurology 1992;42:991-4.
13. Wynn DR, Rodriguez M, O'Fallon WM, et al. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology 1990;40:780-6. (Pubitemid 20159613)
14. Midgard R, Albrektsen G, Riise T, et al. Prognostic factors for survival in multiple sclerosis: A longitudinal, population based study in More and Romsdal, Norway. J Neurol Neurosurg Psychiatry 1995;58:417-21.
15. Ragonese P, Aridon P, Mazzola MA, et al. Multiple sclerosis survival: A population-based study in Sicily. Eur J Neurol 2010;17:391-7.
16. Poser S, Poser W, Schlaf G, et al. Prognostic indicators in multiple sclerosis. Acta Neurol Scand 1986;74:387-92. (Pubitemid 17215197)
17. Paty D, Studney D, Redekop K, et al. MS Costar: A computerized patient record adapted for clinical research purposes. Ann Neurol 1994;(36 Suppl):S134-5. (Pubitemid 24220861)
18. Tremlett H, Zhao Y, Rieckmann P, et al. New perspectives in the natural history of multiple sclerosis. Neurology 2010;74:2004-15.
19. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983;13:227-31. (Pubitemid 13158528)
20. Statistics Canada. Life tables, Canada Provinces and Territories. Reference Period: 2000 to 2002, (updated July 2006). http://www.statcan.gc.ca/ pub/84-537-x/4064441-eng.htm (accessed 13 Sep 2011).
21. Andersen PK, Borch-Johnsen K, Deckert T, et al. A Cox regression model for the relative mortality and its application to diabetes mellitus survival data. Biometrics 1985;41:921-32.
22. Pohar M, Stare J. Relative survival analysis in R. Comput Methods Programs Biomed 2006;81:272-8. (Pubitemid 44316489)
23. Pohar M, Stare J. Making relative survival analysis relatively easy. Comput Biol Med 2007;37:1741-9. (Pubitemid 47575511)
24. Sumelahti ML, Hakama M, Elovaara I, et al. Causes of death among patients with multiple sclerosis. Mult Scler 2010;16:1437-42.
25. Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain 2006;129:595-605. (Pubitemid 43278222)
26. Tremlett H, Paty D, Devonshire V. Disability progression in multiple sclerosis is slower than previously reported. Neurology 2006;66:172-7. (Pubitemid 43970148)
27. Tremlett H, Zhao Y, Devonshire V. Natural history of secondary- progressive multiple sclerosis. Mult Scler 2008;14:314-24. (Pubitemid 351676426)
28. Koch M, Kingwell E, Rieckmann P, et al. The natural history of primary progressive multiple sclerosis. Neurology 2009;73:1996-2002.
29. Koch M, Kingwell E, Rieckmann P, et al. The natural history of secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2010;81:1039-43.
30. McDonnell GV, Hawkins SA. Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK. J Neurol Neurosurg Psychiatry 1998;64:451-4. (Pubitemid 28195944)
31. Cottrell DA, Kremenchutzky M, Rice GP, et al. The natural history of multiple sclerosis: A geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 1999;122:625-39. (Pubitemid 29158771)
32. Kingwell E, Leung AL, Roger E, et al. Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts. J Neurol Sci 2010;292:57-62.
33. Pugliatti M, Sotgiu S, Solinas G, et al. Multiple sclerosis epidemiology in Sardinia: Evidence for a true increasing risk. Acta Neurol Scand 2001;103:20-6.
34. Dahl OP, Aarseth JH, Myhr KM, et al. Multiple sclerosis in Nord-Trondelag County, Norway: A prevalence and incidence study. Acta Neurol Scand 2004;109:378-84. (Pubitemid 38698173)
35. Marrie RA, Cutter G, Tyry T, et al. Changes in the ascertainment of multiple sclerosis. Neurology 2005;65:1066-70. (Pubitemid 41429632)
36. Phadke JG. Survival pattern and cause of death in patients with multiple sclerosis: Results from an epidemiological survey in North East Scotland. J Neurol Neurosurg Psychiatry 1987;50:523-31. (Pubitemid 17067538)
37. Lourenco P, Shirani A, Saeedi J, et al. Oligoclonal banding and CSF markers in multiple sclerosis: Associations with disease course and progression. Int J MS Care 2011;13(Suppl 3):8.
38. Lee JD, Traboulsee AL, Sadovnick AD. Temporal trends in multiple sclerosis incidence among Asians and Caucasians in British Columbia, Canada. Neurology 2011;76(Suppl 4):A475.